Rafael Padilla
Chief Executive Officer
Replay available
Fagron Sa Ord (ARSUF) Q1 2026 Earnings Call
Fagron Sa Ord (OTC: ARSUF) Q1 2026 earnings conference call, held 2026-04-09. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Karin De Jong
Chief Financial Officer
Michael Heider
Analyst, Binnenberg Bank
Frank Class
Analyst, Growth PTCom
Stijn de Meester
Analyst, ING
Erik Wilmer
Analyst, Van Lanschot-Kemper
Martin Verbeek
Analyst, The Idea
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Fagron Sa.
Replay transcript excerpt
WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04265-c7ea-7c90-86f7-b2864120e5ce Created: 2026-08-27T08:46:03.836Z Duration: 2012.064 Channels: 1 00:00:01.760 -- 00:00:05.040 Hello. Good morning, everyone. Welcome to Fagron's First 00:00:05.040 -- 00:00:07.520 Quarter twenty twenty six Trading Update. 00:00:07.680 -- 00:00:10.639 I'm joined today by our CEO, Rafael Padilla 00:00:10.639 -- 00:00:13.405 and our CFO, Karim De Leon. We will 00:00:13.405 -- 00:00:15.485 open the floor for questions at the end 00:00:15.485 -- 00:00:16.605 of the session. 00:00:16.845 -- 00:00:19.164 With that, I will hand over to Rafael. 00:00:19.645 -- 00:00:21.884 Thank you, Ignacio, and good morning all. 00:00:22.204 -- 00:00:24.765 We're pleased to report a solid quarter with 00:00:24.765 -- 00:00:28.204 revenues of €263,000,000 00:00:27.480 -- 00:00:28.360 representing 00:00:28.360 -- 00:00:29.560 10.3% 00:00:29.560 -- 00:00:30.199 growth. 00:00:30.520 -- 00:00:34.120 Results were driven by outstanding performance in LatAm 00:00:34.120 -- 00:00:36.840 and strong contributions from our M and A. 00:00:37.080 -- 00:00:37.800 Brands 00:00:37.960 -- 00:00:40.954 continue to perform well across the board, supported 00:00:40.954 -- 00:00:44.475 by our innovation capabilities and commercial strategy. 00:00:44.954 -- 00:00:46.875 Operational excellence initiatives 00:00:46.875 -- 00:00:49.195 also continue to deliver benefits. 00:00:50.394 -- 00:00:51.434 During the quarter, 00:00:51.754 -- 00:00:53.914 we completed the acquisition of Pharmavit in The 00:00:53.914 -- 00:00:56.989 Netherlands and strengthening our position in the nutraceutical 00:00:56.989 -- 00:00:58.190 ingredients market. 00:00:58.670 -- 00:01:01.710 Also worth mentioning that Pharmavit integration 00:01:01.94...